AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC.

LA JOLLA, CA · Biotech · Defunct

Small-molecule cathepsin B inhibitor drugs (deuterium-labeled derivatives) for traumatic brain injury treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · american.space

Sector: Biotech
Headquarters: LA JOLLA, CA
Latest Form D: $1.1M, May 2016
Total capital: $2.4M

Federal grants: $1.2M; 4 awards · 2018–2019; Rank in peer group#141 of 502
Private capital raised: $1.1M; 1 Form D · last May 2016; 125 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 4 pending · first 2018; Rank in peer group#57 of 502

Capital timeline

Latest events

Aug 2019Federal grantHealth and Human S · Phase I · Administrative Supplement to restore fee funds$36K
Apr 2019Federal grantHealth and Human S · Phase I · Development of a commercialization plan for traumatic brain injury therapeutics$55K
Sep 2018Federal grantHealth and Human S · Phase I · Administrative Supplement to restore fee funds$623K
Sep 2018Federal grantHealth and Human S · Phase I · Cathepsin B inhibitor Drug Development for Traumatic Brain Injury$532K
May 2016Private capital raisedForm D · SEC · 1st filing$1.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 502 peers

Line = median

Biotech · Molecule

Federal grants#141 · top 28%
Granted patents#57 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Gregory D. HookResearcherExecutive Officer, DirectorLinked by $1.2M in grants as PI
Bernice D. WellesDirectorNamed in SEC Form D filings
J. Gregory SwendsenDirectorNamed in SEC Form D filings
Michael D. PierschbacherExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 5

Jul 30, 2020PendingCompositions And Methods For Treating Beta-amyloid Related DiseasesUSPTOApplication 16584667
Jan 17, 2019PendingCompositions And Methods For Treating Beta-amyloid Related DiseasesUSPTOApplication 16003517
Jul 17, 2018GrantedCompositions And Methods For Treating Beta-amyloid Related DiseasesUSPTOUS 10,022,418

Show all 5 patent records

Compositions And Methods For Treating Beta-amyloid Related DiseasesJul 30, 2020 · Application 16584667Pending
Compositions And Methods For Treating Beta-amyloid Related DiseasesJan 17, 2019 · Application 16003517Pending
Compositions And Methods For Treating Beta-amyloid Related DiseasesJul 17, 2018 · US 10,022,418Granted
Compositions And Methods For Synthesizing (2S,3S)-TRANS-EPOXYSUCCINYL-L-LEUCYL-AMIDO-3-METHYLBUTANE Ethyl EsterJun 15, 2017 · Application 15115893Pending
Compositions And Methods For Synthesizing (2S,3S)-TRANS-EPOXYSUCCINYL-L-LEUCYL-AMIDO-3-METHYLBUTANE Ethyl Ester And Loxistatin AcidApplication PCTUS2015014131Pending

MDI THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
NOVILYTIC, LLCSimilar federal contract value in Biotech · null in contracts
OPTIKIRA, LLCSimilar federal contract value in Biotech · null in contracts
7 Hills Pharma LLCSimilar federal contract value in Biotech · null in contracts
AyuVis Research, Inc.Similar federal contract value in Biotech · null in contracts
EPOCH BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.